DEVANTHINIC PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
DEVANTHINIC PHARMA
NACE 82.990, Other business support services
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€888,590
2024 · €983,178-€94,588
Equity
€7.7m
2024 · €6.8m+€888,590
Cash
€351,359
2024 · €462,442-€111,083
Balance sheet total
€16.8m
2024 · €16.7m+€130,397
Largest movements
Assets
- Receivables within one year +€198,104
up €198,104 (+9.7%), from €2.0m to €2.2m
of which Trade receivables: +€235,300
Equity and liabilities
- Debts after one year -€1.2m
down €1.2m (-15.5%), from €7.5m to €6.3m
- Reserves +€463,100
up €463,100 (+86.7%), from €534,150 to €997,250
of which Tax-exempt reserves: +€463,100
- Profit (loss) carried forward +€425,490
up €425,490 (+6.9%), from €6.2m to €6.6m
- Other debts +€186,778
up €186,778 (+14.2%), from €1.3m to €1.5m
- Provisions +€181,018
up €181,018 (+86.6%), from €209,091 to €390,110
Income statement
- Gross operating margin -€77,418
down €77,418 (-5.5%), from €1.4m to €1.3m
- Financial income -€65,000
down €65,000 (-9.6%), from €675,000 to €610,000
- Financial charges -€64,440
down €64,440 (-19.4%), from €331,380 to €266,940
- Staff costs +€64,344
up €64,344 (+17.5%), from €367,160 to €431,503
- Provisions -€28,073
down €28,073 (-13.4%), from €209,091 to €181,018
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
€983,178
Gross operating margin
-€77,418
Staff costs
-€64,344
Depreciation
-€1,717
Provisions
+€28,073
Other operating charges
-€1
Other operating items
+€243
Financial income
-€65,000
Financial charges
+€64,440
Taxes
+€21,136
Result 2025
€888,590
raises the resultlowers the resultnot broken down further in the accounts
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
+€1.1m
Investment
-€44,601
Financing
-€1.2m
Cash 2024
€462,442
From operations (derived)
+€1.1m
Net result for the year
+€888,590
Depreciation
+€3,107
Receivables within one year
-€198,104
Deferred charges and accrued income
-€1,882
Provisions
+€181,018
Trade debts
+€72,369
Tax, wage and social debts
-€37,858
Other debts
+€186,778
Investment (derived)
-€44,601
Investment in fixed assets (net)
-€44,601
Financing
-€1.2m
Debts after one year
-€1.2m
Current portion of long-term debt
+€8,526
Cash 2025
€351,359
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €16,687,393 | €16,817,790 | +€130,397 | +0.8% |
| Fixed assets | 21/28 | €14,182,003 | €14,223,498 | +€41,495 | +0.3% |
| Tangible fixed assets | 22/27 | €3,906 | €34,702 | +€30,796 | +788% |
| Plant, machinery and equipment | 23 | €128 | €517 | +€388 | +303% |
| Furniture and vehicles | 24 | €3,778 | €34,185 | +€30,407 | +805% |
| Financial fixed assets | 28 | €14,178,097 | €14,188,796 | +€10,699 | +0.1% |
| Current assets | 29/58 | €2,505,390 | €2,594,292 | +€88,903 | +3.5% |
| Amounts receivable within one year | 40/41 | €2,042,948 | €2,241,051 | +€198,104 | +9.7% |
| Trade receivables | 40 | €464,126 | €699,425 | +€235,300 | +50.7% |
| Other amounts receivable | 41 | €1,578,822 | €1,541,626 | -€37,196 | -2.4% |
| Cash at bank and in hand | 54/58 | €462,442 | €351,359 | -€111,083 | -24.0% |
| Deferred charges and accrued income | 490/1 | - | €1,882 | +€1,882 | |
| Total equity and liabilities | 10/49 | €16,687,393 | €16,817,790 | +€130,397 | +0.8% |
| Equity | 10/15 | €6,845,363 | €7,733,953 | +€888,590 | +13.0% |
| Contributions | 10/11 | €150,000 | €150,000 | = | 0.0% |
| Reserves | 13 | €534,150 | €997,250 | +€463,100 | +86.7% |
| Non-distributable reserves | 130/1 | €15,000 | €15,000 | = | 0.0% |
| Reserves not available under the articles | 1311 | €15,000 | €15,000 | = | 0.0% |
| Tax-exempt reserves | 132 | €484,150 | €947,250 | +€463,100 | +95.7% |
| Distributable reserves | 133 | €35,000 | €35,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €6,161,213 | €6,586,703 | +€425,490 | +6.9% |
| Provisions and deferred taxes | 16 | €209,091 | €390,110 | +€181,018 | +86.6% |
| Provisions for liabilities and charges | 160/5 | €209,091 | €390,110 | +€181,018 | +86.6% |
| Other liabilities and charges | 164/5 | €209,091 | €390,110 | +€181,018 | +86.6% |
| Amounts payable | 17/49 | €9,632,939 | €8,693,728 | -€939,211 | -9.7% |
| Amounts payable after more than one year | 17 | €7,518,815 | €6,349,788 | -€1.2m | -15.5% |
| Financial debts | 170/4 | €7,518,815 | €6,349,788 | -€1.2m | -15.5% |
| Amounts payable within one year | 42/48 | €2,114,124 | €2,343,940 | +€229,816 | +10.9% |
| Current portion of amounts payable after more than one year | 42 | €585,500 | €594,027 | +€8,526 | +1.5% |
| Trade debts | 44 | €99,603 | €171,972 | +€72,369 | +72.7% |
| Suppliers | 440/4 | €99,603 | €171,972 | +€72,369 | +72.7% |
| Taxes, remuneration and social security | 45 | €110,385 | €72,526 | -€37,858 | -34.3% |
| Taxes | 450/3 | €75,082 | €10,903 | -€64,179 | -85.5% |
| Remuneration and social security | 454/9 | €35,303 | €61,624 | +€26,321 | +74.6% |
| Other amounts payable | 47/48 | €1,318,636 | €1,505,414 | +€186,778 | +14.2% |
| Remuneration, social security and pensions | 62 | €367,160 | €431,503 | +€64,344 | +17.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,389 | €3,107 | +€1,717 | +124% |
| Provisions for liabilities and charges: additions (uses and reversals) | 635/8 | €209,091 | €181,018 | -€28,073 | -13.4% |
| Other operating charges | 640/8 | €0 | €1 | +€1 | +2,380% |
| Non-recurring operating charges | 66A | €243 | - | -€243 | |
| Gross operating margin | 9900 | €1,396,786 | €1,319,368 | -€77,418 | -5.5% |
| Operating profit (loss) | 9901 | €818,903 | €703,739 | -€115,164 | -14.1% |
| Financial income | 75/76B | €675,000 | €610,000 | -€65,000 | -9.6% |
| Recurring financial income | 75 | €675,000 | €610,000 | -€65,000 | -9.6% |
| Financial charges | 65/66B | €331,380 | €266,940 | -€64,440 | -19.4% |
| Recurring financial charges | 65 | €331,380 | €266,940 | -€64,440 | -19.4% |
| Profit (loss) for the period before taxes | 9903 | €1,162,522 | €1,046,798 | -€115,724 | -10.0% |
| Income taxes | 67/77 | €179,345 | €158,208 | -€21,136 | -11.8% |
| Profit (loss) for the period | 9904 | €983,178 | €888,590 | -€94,588 | -9.6% |
| Transfer to tax-exempt reserves | 689 | €273,650 | €463,100 | +€189,450 | +69.2% |
| Profit (loss) for the period to be appropriated | 9905 | €709,528 | €425,490 | -€284,038 | -40.0% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 23 October 2026 via checked.be.